EPB41L4A and lung cancer: According to multivariable analysis results, AJCC stage T was associated with an increased risk of death (hazard ratio [HR] 2.77, 95% CI 1.22–6.26, P = 0.015) in lncRNA EPB41L4A-AS1 low expressed adenocarcinoma lung cancer patients.